HEALTHY LIVING
DEPRESSION: PROBIOTICS MAY HELP For a study published in
OZEMPIC MAY PROTECT BONES People with Type 2 diabetes who take the weight-loss drug semaglutide (Wegovy) may also be protected against bone fractures. A Stanford University
THE LATEST RESEARCH
Treat Skin Diseases G
lp-1 drugs used to treat obesity and Type 2 diabetes may also
help treat several inflammatory skin conditions, according to a scientific review published in Pharmaceutics. Researchers found that GLP-1
receptor agonists may benefit people with psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and chronic wounds. Studies suggest the drugs reduce the production of pro-inflammatory cytokines, including TNF-alpha, IL-6, and IL-17, which play key roles in psoriasis and other
R
GLP-1 Drugs May Help
Medical Center study of nearly 60,000 adults found that in addition to losing more weight, those taking semaglutide experienced about 15% fewer fractures than those taking other weight-loss medications.
inflammatory skin diseases. “Today, we know that psoriasis
and atopic dermatitis are not merely skin diseases,” says Małgorzata Ponikowska, M.D., of Wroclaw Medical University. “The chronic inflammation associated with them can affect the functioning of the entire body and increase the risk of developing other conditions, particularly metabolic and cardiovascular diseases.” Increasing evidence indicates
GLP-1 drugs such as semaglutide (Wegovy) may modulate immune responses rather than merely influence metabolism, according to Ponikowska. The medications may promote skin repair, which could be especially beneficial for people with diabetes who often struggle with chronic wounds.
Weight-Loss Drugs Lower Breast Cancer Risk
esearchers at Penn Medicine
analyzed the health records of 111,646 overweight women and found that those who took GLP-1 medications — including Ozempic, Wegovy, Mounjaro,
and Victoza — had about a 30% lower risk of developing breast cancer than those who did not take the drugs. The researchers
believe the benefit may be related to the medications’ anti- inflammatory effects.
102 NEWSMAX MAXLIFE | OCTOBER 2026
Chronic, low-grade inflammation is thought to contribute to the development of breast cancer, and GLP-1 drugs have been shown to reduce inflammation throughout the body.
the Journal of the American Geriatrics Society, older adults with moderate depression were randomly assigned to receive either a daily probiotic or a placebo for 12 weeks. Participants who took probiotics
experienced meaningful reductions in symptoms of depression and anxiety, while those who took a placebo did not.
AUTISM: ANXIETY RISES WITH AGE A study published in Nature Mental Health
found that while most middle-aged and older adults reported consistently low levels of anxiety, those with higher levels of autistic traits were much more likely to experience worsening anxiety over time. During the eight-year study, participants with high autistic traits were four times more likely to report a significant increase in anxiety than those without autistic traits.
CANCER: ASTHMA DRUG MAY FIGHT AGGRESSIVE CANCER Montelukast (Singulair), a drug
commonly used to treat asthma and allergies, may also fight aggressive cancers, such as triple-negative breast cancer. A study published in Nature
Cancer found that montelukast blocks a molecule called CysLTR1, which spurs asthma and inflammation. Blocking the CysLTR1 pathway slowed tumor growth, improved survival, and restored response to immunotherapy, even in tumors that had already stopped responding to treatment.
LIVER: NAPS MAY INCREASE RISK OF CHRONIC LIVER DISEASE People with Type 2 diabetes who nap longer than 30 minutes daily increase their risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers at China’s Wenzhou Medical University followed 1,900 adults with Type 2 diabetes for three years. “Our work suggests long naps independently
increase the likelihood of MASLD in individuals with Type 2 diabetes,” said Xuejiang Gu, M.D., Ph.D. “However, poor nocturnal sleep combined with long naps more than triples MASLD risk.”
BONE/
ISTOCK.COM/POP_JOP / RIBBON/
ISTOCK.COM/T_KIMURA / BRAIN/
ISTOCK.COM/JDAWNINK SCALE/AFRICA STUDIO/SHUTTERSTOCK / NAP/APRINT/SHUTTERSTOCK / LIVER/USWA KDT/SHUTTERSTOCK
SINGULAIR/RICK FRIEDMAN/CORBIS VIA GETTY IMAGES OZEMPIC/ALONES/SHUTTERSTOCK / MAN/PROSTOCK-STUDIO/SHUTTERSTOCK
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108
